HEADER TRANSCRIPTION 02-JUL-19 6S69 TITLE CRYSTAL STRUCTURE OF HTEAD2 IN COMPLEX WITH A TRISUBSTITUTED PYRAZOLE TITLE 2 INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: TRANSCRIPTIONAL ENHANCER FACTOR TEF-4; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: TEA DOMAIN FAMILY MEMBER 2,TEAD-2; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: TEAD2, TEF4; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS TEAD2, INHIBITOR, TRANSCRIPTION EXPDTA X-RAY DIFFRACTION AUTHOR M.STURBAUT,F.ALLEMAND,J.F.GUICHOU REVDAT 2 02-FEB-22 6S69 1 JRNL REVDAT 1 22-JUL-20 6S69 0 JRNL AUTH M.STURBAUT,F.BAILLY,M.COEVOET,P.SILEO,M.PUGNIERE, JRNL AUTH 2 M.LIBERELLE,R.MAGNEZ,X.THURU,M.C.CHARTIER-HARLIN,P.MELNYK, JRNL AUTH 3 M.GELIN,F.ALLEMAND,J.F.GUICHOU,P.COTELLE JRNL TITL DISCOVERY OF A CRYPTIC SITE AT THE INTERFACE 2 OF TEAD - JRNL TITL 2 TOWARDS A NEW FAMILY OF YAP/TAZ-TEAD INHIBITORS. JRNL REF EUR.J.MED.CHEM. V. 226 13835 2021 JRNL REFN ISSN 0223-5234 JRNL PMID 34509860 JRNL DOI 10.1016/J.EJMECH.2021.113835 REMARK 2 REMARK 2 RESOLUTION. 2.15 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.15 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 70.90 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 92.7 REMARK 3 NUMBER OF REFLECTIONS : 25295 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.203 REMARK 3 R VALUE (WORKING SET) : 0.200 REMARK 3 FREE R VALUE : 0.255 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 1308 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3288 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 60 REMARK 3 SOLVENT ATOMS : 33 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 63.87 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.01000 REMARK 3 B22 (A**2) : -0.01000 REMARK 3 B33 (A**2) : 0.02000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.01000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.242 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.209 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.204 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 8.697 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : NULL ; NULL REMARK 3 ANGLE DISTANCE (A) : NULL ; NULL REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : NULL ; NULL REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : NULL ; NULL REMARK 3 STAGGERED (DEGREES) : NULL ; NULL REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 6S69 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 02-JUL-19. REMARK 100 THE DEPOSITION ID IS D_1292103187. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-DEC-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 2 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : BM30A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.966 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 S 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 27656 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.150 REMARK 200 RESOLUTION RANGE LOW (A) : 70.900 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.4 REMARK 200 DATA REDUNDANCY : 1.700 REMARK 200 R MERGE (I) : 0.02800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.15 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.23 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.39500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.10 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.42 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2.8M SODIUM FORMATE, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 60.76950 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 30.83250 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 60.76950 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 30.83250 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 216 REMARK 465 ALA A 217 REMARK 465 TRP A 218 REMARK 465 GLN A 219 REMARK 465 ALA A 220 REMARK 465 ARG A 221 REMARK 465 PRO A 240 REMARK 465 ASP A 241 REMARK 465 ALA A 242 REMARK 465 VAL A 243 REMARK 465 ASP A 244 REMARK 465 SER A 245 REMARK 465 TYR A 246 REMARK 465 GLN A 247 REMARK 465 HIS A 257 REMARK 465 CYS A 258 REMARK 465 PRO A 259 REMARK 465 SER A 260 REMARK 465 PRO A 261 REMARK 465 GLY A 262 REMARK 465 ALA A 263 REMARK 465 PRO A 264 REMARK 465 PRO A 265 REMARK 465 GLY A 309 REMARK 465 PRO A 310 REMARK 465 SER A 311 REMARK 465 GLY A 312 REMARK 465 GLU A 313 REMARK 465 GLU A 314 REMARK 465 ALA A 315 REMARK 465 GLY A 316 REMARK 465 ALA A 317 REMARK 465 GLY A 318 REMARK 465 GLY A 319 REMARK 465 SER A 320 REMARK 465 ILE A 321 REMARK 465 SER A 322 REMARK 465 SER A 323 REMARK 465 GLY A 324 REMARK 465 ASP A 447 REMARK 465 VAL A 448 REMARK 465 GLU A 449 REMARK 465 HIS A 450 REMARK 465 HIS A 451 REMARK 465 HIS A 452 REMARK 465 HIS A 453 REMARK 465 HIS A 454 REMARK 465 HIS A 455 REMARK 465 MET B 216 REMARK 465 ALA B 217 REMARK 465 TRP B 218 REMARK 465 GLN B 219 REMARK 465 CYS B 258 REMARK 465 PRO B 259 REMARK 465 SER B 260 REMARK 465 PRO B 261 REMARK 465 GLY B 262 REMARK 465 ALA B 263 REMARK 465 GLY B 309 REMARK 465 PRO B 310 REMARK 465 SER B 311 REMARK 465 GLY B 312 REMARK 465 GLU B 313 REMARK 465 GLU B 314 REMARK 465 ALA B 315 REMARK 465 GLY B 316 REMARK 465 ALA B 317 REMARK 465 GLY B 318 REMARK 465 GLY B 319 REMARK 465 SER B 320 REMARK 465 ILE B 321 REMARK 465 SER B 322 REMARK 465 ASP B 447 REMARK 465 VAL B 448 REMARK 465 GLU B 449 REMARK 465 HIS B 450 REMARK 465 HIS B 451 REMARK 465 HIS B 452 REMARK 465 HIS B 453 REMARK 465 HIS B 454 REMARK 465 HIS B 455 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 253 114.32 -171.57 REMARK 500 PRO A 294 -37.16 -39.46 REMARK 500 ASP A 367 45.94 39.28 REMARK 500 GLN A 418 -0.46 76.34 REMARK 500 LYS B 282 -102.34 -169.64 REMARK 500 VAL B 354 -55.98 -122.49 REMARK 500 GLU B 366 -150.23 -99.44 REMARK 500 ARG B 369 145.88 -174.31 REMARK 500 LEU B 374 73.80 -118.43 REMARK 500 GLN B 418 17.52 58.42 REMARK 500 SER B 433 -54.80 80.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue MYR A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue KX5 B 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide MYR B 501 and CYS B REMARK 800 380 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 6S60 RELATED DB: PDB DBREF 6S69 A 217 447 UNP Q15562 TEAD2_HUMAN 217 447 DBREF 6S69 B 217 447 UNP Q15562 TEAD2_HUMAN 217 447 SEQADV 6S69 MET A 216 UNP Q15562 INITIATING METHIONINE SEQADV 6S69 VAL A 448 UNP Q15562 EXPRESSION TAG SEQADV 6S69 GLU A 449 UNP Q15562 EXPRESSION TAG SEQADV 6S69 HIS A 450 UNP Q15562 EXPRESSION TAG SEQADV 6S69 HIS A 451 UNP Q15562 EXPRESSION TAG SEQADV 6S69 HIS A 452 UNP Q15562 EXPRESSION TAG SEQADV 6S69 HIS A 453 UNP Q15562 EXPRESSION TAG SEQADV 6S69 HIS A 454 UNP Q15562 EXPRESSION TAG SEQADV 6S69 HIS A 455 UNP Q15562 EXPRESSION TAG SEQADV 6S69 MET B 216 UNP Q15562 INITIATING METHIONINE SEQADV 6S69 VAL B 448 UNP Q15562 EXPRESSION TAG SEQADV 6S69 GLU B 449 UNP Q15562 EXPRESSION TAG SEQADV 6S69 HIS B 450 UNP Q15562 EXPRESSION TAG SEQADV 6S69 HIS B 451 UNP Q15562 EXPRESSION TAG SEQADV 6S69 HIS B 452 UNP Q15562 EXPRESSION TAG SEQADV 6S69 HIS B 453 UNP Q15562 EXPRESSION TAG SEQADV 6S69 HIS B 454 UNP Q15562 EXPRESSION TAG SEQADV 6S69 HIS B 455 UNP Q15562 EXPRESSION TAG SEQRES 1 A 240 MET ALA TRP GLN ALA ARG GLY LEU GLY THR ALA ARG LEU SEQRES 2 A 240 GLN LEU VAL GLU PHE SER ALA PHE VAL GLU PRO PRO ASP SEQRES 3 A 240 ALA VAL ASP SER TYR GLN ARG HIS LEU PHE VAL HIS ILE SEQRES 4 A 240 SER GLN HIS CYS PRO SER PRO GLY ALA PRO PRO LEU GLU SEQRES 5 A 240 SER VAL ASP VAL ARG GLN ILE TYR ASP LYS PHE PRO GLU SEQRES 6 A 240 LYS LYS GLY GLY LEU ARG GLU LEU TYR ASP ARG GLY PRO SEQRES 7 A 240 PRO HIS ALA PHE PHE LEU VAL LYS PHE TRP ALA ASP LEU SEQRES 8 A 240 ASN TRP GLY PRO SER GLY GLU GLU ALA GLY ALA GLY GLY SEQRES 9 A 240 SER ILE SER SER GLY GLY PHE TYR GLY VAL SER SER GLN SEQRES 10 A 240 TYR GLU SER LEU GLU HIS MET THR LEU THR CYS SER SER SEQRES 11 A 240 LYS VAL CYS SER PHE GLY LYS GLN VAL VAL GLU LYS VAL SEQRES 12 A 240 GLU THR GLU ARG ALA GLN LEU GLU ASP GLY ARG PHE VAL SEQRES 13 A 240 TYR ARG LEU LEU ARG SER PRO MET CYS GLU TYR LEU VAL SEQRES 14 A 240 ASN PHE LEU HIS LYS LEU ARG GLN LEU PRO GLU ARG TYR SEQRES 15 A 240 MET MET ASN SER VAL LEU GLU ASN PHE THR ILE LEU GLN SEQRES 16 A 240 VAL VAL THR ASN ARG ASP THR GLN GLU LEU LEU LEU CYS SEQRES 17 A 240 THR ALA TYR VAL PHE GLU VAL SER THR SER GLU ARG GLY SEQRES 18 A 240 ALA GLN HIS HIS ILE TYR ARG LEU VAL ARG ASP VAL GLU SEQRES 19 A 240 HIS HIS HIS HIS HIS HIS SEQRES 1 B 240 MET ALA TRP GLN ALA ARG GLY LEU GLY THR ALA ARG LEU SEQRES 2 B 240 GLN LEU VAL GLU PHE SER ALA PHE VAL GLU PRO PRO ASP SEQRES 3 B 240 ALA VAL ASP SER TYR GLN ARG HIS LEU PHE VAL HIS ILE SEQRES 4 B 240 SER GLN HIS CYS PRO SER PRO GLY ALA PRO PRO LEU GLU SEQRES 5 B 240 SER VAL ASP VAL ARG GLN ILE TYR ASP LYS PHE PRO GLU SEQRES 6 B 240 LYS LYS GLY GLY LEU ARG GLU LEU TYR ASP ARG GLY PRO SEQRES 7 B 240 PRO HIS ALA PHE PHE LEU VAL LYS PHE TRP ALA ASP LEU SEQRES 8 B 240 ASN TRP GLY PRO SER GLY GLU GLU ALA GLY ALA GLY GLY SEQRES 9 B 240 SER ILE SER SER GLY GLY PHE TYR GLY VAL SER SER GLN SEQRES 10 B 240 TYR GLU SER LEU GLU HIS MET THR LEU THR CYS SER SER SEQRES 11 B 240 LYS VAL CYS SER PHE GLY LYS GLN VAL VAL GLU LYS VAL SEQRES 12 B 240 GLU THR GLU ARG ALA GLN LEU GLU ASP GLY ARG PHE VAL SEQRES 13 B 240 TYR ARG LEU LEU ARG SER PRO MET CYS GLU TYR LEU VAL SEQRES 14 B 240 ASN PHE LEU HIS LYS LEU ARG GLN LEU PRO GLU ARG TYR SEQRES 15 B 240 MET MET ASN SER VAL LEU GLU ASN PHE THR ILE LEU GLN SEQRES 16 B 240 VAL VAL THR ASN ARG ASP THR GLN GLU LEU LEU LEU CYS SEQRES 17 B 240 THR ALA TYR VAL PHE GLU VAL SER THR SER GLU ARG GLY SEQRES 18 B 240 ALA GLN HIS HIS ILE TYR ARG LEU VAL ARG ASP VAL GLU SEQRES 19 B 240 HIS HIS HIS HIS HIS HIS HET MYR A 501 16 HET MYR B 501 15 HET KX5 B 502 29 HETNAM MYR MYRISTIC ACID HETNAM KX5 3-[3-(3,4-DICHLOROPHENYL)-4-(2-PHENYLETHYLCARBAMOYL) HETNAM 2 KX5 PYRAZOL-1-YL]PROPANOIC ACID FORMUL 3 MYR 2(C14 H28 O2) FORMUL 5 KX5 C21 H19 CL2 N3 O3 FORMUL 6 HOH *33(H2 O) HELIX 1 AA1 ARG A 272 PHE A 278 5 7 HELIX 2 AA2 GLY A 284 GLY A 292 1 9 HELIX 3 AA3 PRO A 293 HIS A 295 5 3 HELIX 4 AA4 CYS A 380 LEU A 393 1 14 HELIX 5 AA5 GLU A 395 GLU A 404 1 10 HELIX 6 AA6 PRO B 239 VAL B 243 5 5 HELIX 7 AA7 ARG B 272 PHE B 278 5 7 HELIX 8 AA8 GLY B 284 GLY B 292 1 9 HELIX 9 AA9 PRO B 293 HIS B 295 5 3 HELIX 10 AB1 CYS B 380 LEU B 393 1 14 HELIX 11 AB2 GLU B 395 ASN B 405 1 11 SHEET 1 AA1 5 HIS A 249 SER A 255 0 SHEET 2 AA1 5 GLN A 229 GLU A 238 -1 N VAL A 237 O HIS A 249 SHEET 3 AA1 5 PHE A 326 SER A 335 -1 O GLN A 332 N VAL A 231 SHEET 4 AA1 5 ARG A 369 PRO A 378 -1 O LEU A 374 N SER A 331 SHEET 5 AA1 5 GLN A 364 GLU A 366 -1 N GLN A 364 O VAL A 371 SHEET 1 AA214 SER A 268 ASP A 270 0 SHEET 2 AA214 GLN A 438 VAL A 445 1 O VAL A 445 N VAL A 269 SHEET 3 AA214 PHE A 297 ALA A 304 -1 N LEU A 299 O TYR A 442 SHEET 4 AA214 LEU A 420 VAL A 430 1 O VAL A 427 N PHE A 302 SHEET 5 AA214 PHE A 406 ASN A 414 -1 N VAL A 412 O LEU A 422 SHEET 6 AA214 THR A 340 SER A 349 -1 N LYS A 346 O LEU A 409 SHEET 7 AA214 LYS A 352 ARG A 362 -1 O GLU A 361 N LEU A 341 SHEET 8 AA214 LYS B 352 ARG B 362 1 O VAL B 358 N VAL A 358 SHEET 9 AA214 THR B 340 SER B 349 -1 N CYS B 343 O GLU B 359 SHEET 10 AA214 PHE B 406 ASN B 414 -1 O LEU B 409 N LYS B 346 SHEET 11 AA214 LEU B 420 VAL B 430 -1 O LEU B 421 N VAL B 412 SHEET 12 AA214 PHE B 297 ALA B 304 1 N ALA B 304 O GLU B 429 SHEET 13 AA214 GLN B 438 VAL B 445 -1 O TYR B 442 N LEU B 299 SHEET 14 AA214 SER B 268 ASP B 270 1 N VAL B 269 O ARG B 443 SHEET 1 AA3 5 HIS B 249 SER B 255 0 SHEET 2 AA3 5 GLN B 229 GLU B 238 -1 N PHE B 233 O ILE B 254 SHEET 3 AA3 5 PHE B 326 SER B 335 -1 O GLN B 332 N VAL B 231 SHEET 4 AA3 5 ARG B 369 PRO B 378 -1 O LEU B 374 N SER B 331 SHEET 5 AA3 5 GLN B 364 GLU B 366 -1 N GLN B 364 O VAL B 371 LINK SG CYS B 380 C1 MYR B 501 1555 1555 1.67 CISPEP 1 GLY A 292 PRO A 293 0 2.12 CISPEP 2 GLY B 292 PRO B 293 0 5.95 SITE 1 AC1 6 PHE A 233 ALA A 235 LYS A 357 MET A 379 SITE 2 AC1 6 CYS A 380 ILE A 408 SITE 1 AC2 5 LYS A 352 TYR A 397 SER B 349 VAL B 354 SITE 2 AC2 5 TYR B 382 SITE 1 AC3 11 ALA B 235 SER B 345 PRO B 378 MET B 379 SITE 2 AC3 11 GLU B 381 TYR B 382 LEU B 383 VAL B 384 SITE 3 AC3 11 LEU B 387 ILE B 408 PHE B 428 CRYST1 121.539 61.665 80.055 90.00 117.66 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008228 0.000000 0.004313 0.00000 SCALE2 0.000000 0.016217 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014103 0.00000